Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The changing clinical course of multiple sclerosis: A matter of grey matter.
The efficacy and safety of natalizumab for the treatment of multiple sclerosis in Portugal: a retrospective study.
Natalizumab treatment of progressive multiple sclerosis (NAPMS)
Simvastatin affects cell motility and actin cytoskeleton distribution of microglia.
Altered collagen expression in jugular veins in multiple sclerosis.
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
Cerebrospinal fluid α-synuclein levels are elevated in multiple sclerosis and neuromyelitis optica patients during replase.
Feature Article: Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications.
dNP2 is a blood-brain barrier-permeable peptide enabling ctCTLA-4 protein delivery to ameliorate experimental autoimmune encephalomyelitis.
Mice devoid of tau have increased susceptibility to neuronal damage in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis.
Aging and multiple sclerosis.
[Recurring neuromyelitis without optic neuritis: a case report].
Epitope-specific CD8+ T cells play a differential pathogenic role in the development of a viral disease model for multiple sclerosis.
Lack of neuroprotective effects of simvastatin and minocycline in a model of cervical spinal cord injury.
A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis.
Vitamin B12 deficiency mimicking NMO spectrum disorder.
Focus on Extracellular Vesicles: Therapeutic Potential of Stem Cell-Derived Extracellular Vesicles.
Scoring treatment response in patients with relapsing multiple sclerosis.
Chronic cerebrospinal venous insufficiency and venous stenoses in multiple sclerosis.
Disruption of oligodendrocyte gap junctions in experimental autoimmune encephalomyelitis.
Safety and efficacy of fingolimod in clinical practice: The experience of an academic center in the Middle East.
Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a nation-wide cohort.
Y-39983, a Selective Rho-Kinase Inhibitor, Attenuates Experimental Autoimmune Encephalomyelitis via Inhibition of Demyelination.
Autoregulatory CD8 T cells depend on cognate antigen recognition and CD4/CD8 myelin determinants.
A bird's-eye view of T cells during natalizumab therapy.

Pages